Cardiology journal · 2016
Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
СтатьяМногоцентровое исследованиеРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Husaini Mustafa, Biton Yitschak, Stair Brad, Moss Arthur J, Biering-Sørensen Tor, Solomon Scott, McNitt Scott, Polonsky Bronislava, Zareba Wojciech, Barsheshet Alon, Kutyifa Valentina
Аннотация
BACKGROUND: It is not known whether the number of revascularizations modifies clinical outcomes in patients with ischemic cardiomyopathy (ICM) implanted with cardiac resynchronization therapy defibrillator (CRT-D) vs. an implantable cardioverter-defibrillator (ICD)-only.
METHODS: In Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT), we evaluated the effect of CRT-D vs. ICD-only on heart failure (HF) or death, on ventricular tachycardia (VT), ventricular fibrillation (VF) or death, and on reverse remodeling in 592 ICM patients with left bundle branch block, by the number of pre-enrollment revascularizations (0, 1 or ≥ 2 revascularizations).
RESULTS: There was a risk reduction of HF/death with CRT-D vs. ICD-only in all three sub-groups: ICM with no need for revascularization (HR 0.51 [0.26-1.02]; p = 0.055), ICM with 1 revascularization (HR 0.45 [0.30-0.70]; p < 0.001), and ICM with 2 or more revas-cularizations (HR 0.37 [0.20-0.66]; p < 0.001). Similarly, there was a risk reduction of VT/ /VF/death with CRT-D vs. ICD-only in patients with no need for revascularization (HR 0.55 [0.31-0.99]; p = 0.044); with 1 revascularization (HR 0.77 [0.51-1.18]; p = 0.23); or with ≥ 2 revascularizations (HR 0.63 [0.34-1.17]; p = 0.14). There was a similar degree of left ventricular reverse remodeling in all three subgroups (p > 0.05 for LVESV, LVEDV, and LAV percent change at 1-year follow-up).
CONCLUSIONS: In ICM patients, CRT-D is associated with a reduction in HF or death and VT/VF or death - irrespective of the frequency of pre-enrollment revascularization procedures - and is accompanied by a similar degree of beneficial left ventricular reverse remodeling.
METHODS: In Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT), we evaluated the effect of CRT-D vs. ICD-only on heart failure (HF) or death, on ventricular tachycardia (VT), ventricular fibrillation (VF) or death, and on reverse remodeling in 592 ICM patients with left bundle branch block, by the number of pre-enrollment revascularizations (0, 1 or ≥ 2 revascularizations).
RESULTS: There was a risk reduction of HF/death with CRT-D vs. ICD-only in all three sub-groups: ICM with no need for revascularization (HR 0.51 [0.26-1.02]; p = 0.055), ICM with 1 revascularization (HR 0.45 [0.30-0.70]; p < 0.001), and ICM with 2 or more revas-cularizations (HR 0.37 [0.20-0.66]; p < 0.001). Similarly, there was a risk reduction of VT/ /VF/death with CRT-D vs. ICD-only in patients with no need for revascularization (HR 0.55 [0.31-0.99]; p = 0.044); with 1 revascularization (HR 0.77 [0.51-1.18]; p = 0.23); or with ≥ 2 revascularizations (HR 0.63 [0.34-1.17]; p = 0.14). There was a similar degree of left ventricular reverse remodeling in all three subgroups (p > 0.05 for LVESV, LVEDV, and LAV percent change at 1-year follow-up).
CONCLUSIONS: In ICM patients, CRT-D is associated with a reduction in HF or death and VT/VF or death - irrespective of the frequency of pre-enrollment revascularization procedures - and is accompanied by a similar degree of beneficial left ventricular reverse remodeling.